Скачать или смотреть News: A Tailored Approach: Evidence-Based Management Strategies for Advanced/Metastatic ncc-RCC

Renal cell carcinomas (RCCs) are one of the most common urologic malignancies and, of the RCCs, heterogeneous non–clear cell RCC (nccRCC) represent ~25% of RCCs, with papillary carcinomas being the most common, followed by chromophobe subtype. When patients present with advanced or metastatic nccRCC, the 5-year overall survival rate has been historically very low; however, there is a rapidly expanding systemic therapy landscape in this field. In this Oncology News: nccRCC edition, Drs. Sumanta Pal and Wesley Yip will discuss the most recent data and their expert opinions regarding how to individualize surgical and systemic therapies for the treatment of advanced/metastatic nccRCC, with particular emphasis on papillary and chromophobe subtypes.

View this CME program in its entirety
https://exchangecme.com/OncNewsRCC

Access Clinical Tools, Guidelines, Resources
https://exchangecme.com/OncNewsRCCRes...

#kidneycancer #kidney #clinicaltrials #renal

ExchangeCME.com is an online community of more than 57,000 active healthcare professionals who have access to a variety of enduring educational activities and other disease state–focused resources. The Website’s core mission is to support patient-centered care via education that is tailored to the needs of various clinician audiences.

By consolidating evidence-based resources and hosting only accredited educational programs without any promotional content or advertising, ExchangeCME.com serves as an independent, trusted, and balanced source of free CME/CE for physicians, nurses, pharmacists, and other healthcare providers.

Follow us on social!
twitter:   / exchangecme  
facebook:   / exchangecme  
linkedin:   / exch.  .